The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACCELERATE DIAGNOSTICS INC | COM | 00430H102 | 49,026 | 2,183,795 | SH | SOLE | 2,183,795 | 0 | 0 | ||
ACCELERON PHARMA INC | COM | 00434H108 | 933 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
ADVANCED ACCELERATOR APPLICATIONS SA | COM | 00790T100 | 1,488 | 22,000 | SH | SOLE | 22,000 | 0 | 0 | ||
AEVI GENOMIC MEDICINE INC | COM | 00835P105 | 161 | 128,000 | SH | SOLE | 128,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 151 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 313 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||
BIOLASE INC | COM | 090911108 | 775 | 1,285,903 | SH | SOLE | 1,285,903 | 0 | 0 | ||
CELGENE CORP | RIGHT 12/31/2030 | 151020112 | 443 | 291,877 | SH | SOLE | 291,877 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 110,976 | 761,051 | SH | SOLE | 761,051 | 0 | 0 | ||
CLEMENTIA PHARMACEUTICALS INC | COM | 185575107 | 372 | 22,000 | SH | SOLE | 22,000 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 412 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
CONTRAFECT CORP | COM | 212326102 | 1,260 | 1,135,082 | SH | SOLE | 1,135,082 | 0 | 0 | ||
CORCEPT THERAPEUTICS INC | COM | 218352102 | 1,834 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
CYTOKINETICS INC | COM | 23282W605 | 145 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 259 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
ENCANA CORP | COM | 292505104 | 1,558 | 132,300 | SH | SOLE | 132,300 | 0 | 0 | ||
EQT CORP | COM | 26884L109 | 2,760 | 42,300 | SH | SOLE | 42,300 | 0 | 0 | ||
GENOCEA BIOSCIENCES INC | COM | 372427104 | 57 | 39,000 | SH | SOLE | 39,000 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS INC | COM | 45845P108 | 250 | 4,300 | SH | SOLE | 4,300 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | COM | 46333XAD0 | 158 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
MASIMO CORP | COM | 574795100 | 692 | 8,000 | SH | SOLE | 8,000 | 0 | 0 | ||
MERCK & CO INC | COM | 58933Y105 | 640 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 3,211 | 52,400 | SH | SOLE | 52,400 | 0 | 0 | ||
ONCOMED PHARMACEUTICALS INC | COM | 68234X102 | 130 | 28,689 | SH | SOLE | 28,689 | 0 | 0 | ||
OXFORD IMMUNOTEC GLOBAL PLC | COM | G6855A103 | 1,299 | 77,303 | SH | SOLE | 77,303 | 0 | 0 | ||
PIONEER NATURAL RESOURCES CO | COM | 723787107 | 443 | 3,000 | SH | SOLE | 3,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 235 | 3,632 | SH | SOLE | 3,632 | 0 | 0 | ||
QUIDEL CORP | COM | 74838J101 | 1,709 | 38,975 | SH | SOLE | 38,975 | 0 | 0 | ||
QUOTIENT LTD | COM | G73268107 | 294 | 59,700 | SH | SOLE | 59,700 | 0 | 0 | ||
SIENTRA INC | COM | 82621J105 | 975 | 63,300 | SH | SOLE | 63,300 | 0 | 0 | ||
SITO MOBILE LTD | COM | 82988R203 | 857 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 671 | 5,200 | SH | SOLE | 5,200 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 1,217 | 68,000 | SH | SOLE | 68,000 | 0 | 0 | ||
VERACYTE INC | COM | 92337F107 | 1,042 | 118,767 | SH | SOLE | 118,767 | 0 | 0 | ||
VERMILLION INC | COM | 92407M206 | 4,433 | 2,462,933 | SH | SOLE | 2,462,933 | 0 | 0 | ||
VOYAGER THERAPEUTICS INC | COM | 92915B106 | 494 | 24,000 | SH | SOLE | 24,000 | 0 | 0 | ||
WORKHORSE GROUP INC | COM | 98138J206 | 138 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
WRIGHT MEDICAL GROUP NV | COM | 98235T107 | 776 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 282 | 12,300 | SH | SOLE | 12,300 | 0 | 0 | ||
YIELD10 BIOSCIENCE INC | COM | 98585k102 | 722 | 226,317 | SH | SOLE | 226,317 | 0 | 0 |